ABSTRACT OBJECTIVES: 1) To examine associations between racial discrimination and drug problems among urban-based Aboriginal adults; and 2) to determine whether these associations are best explained by symptoms of psychological stress, distress or post-traumatic stress disorder (PTSD).
A boriginal peoples experience a disproportionate burden of drug problems with serious implications for health. 1, 2 To date, we do not have a common understanding of the determinants underlying these disparities. Research suggests that a social determinant of particular relevance for health disparities is racial discrimination. [3] [4] [5] [6] [7] In Canada, racism and its impacts on Aboriginal health have received little attention in the scientific literature. Racism is an ideology that ranks some groups as inferior on the basis of their ethnicity or phenotypic characteristics. 8 Racism informs action by justifying the prejudicial attitudes and unfair treatment (discrimination) of individuals and institutions against visible minorities.
8 Targets are aware of some of the discriminatory behaviour directed at them, which often generates significant levels of stress. 9 A number of conceptual models have been used to describe the impacts of discrimination on health. A prevailing paradigm is the stress and coping framework. This model focuses on the psychological stress associated with discrimination and the use of coping strategies to control these reactions. 10 Currently, the boundaries of the framework are being pushed by an expanding body of evidence suggesting that individuals may have visceral reactions to discrimination that extend beyond their psychological control. More than a dozen experimental studies now document that discrimination causes visceral physiologic stress responses across racial groups. 3 Discrimination has been associated not only with poor mental health but also stressinduced endocrine dysfunction, cardiovascular dysfunction, shortened telomere length, and other markers of accelerated aging. 11 Discrimination may also reduce an individual's selfcontrol resources, resulting in less energy to elicit effective coping strategies and behavioural choices. 3 Pertinent to this study, longitudinal research has shown that discrimination results in prospective increases in substance use over time. 7 Although the mechanisms through which discrimination impacts substance use likely extend beyond psychological stress or distress, explanations are often limited to these emotions. A few studies have considered the impacts of discrimination on the development of post-traumatic stress disorder (PTSD). [11] [12] [13] [14] [15] For example, a recent study found PTSD symptoms can explain associations between discrimination and health behaviour, including substance use. 5 Yet research to date has not examined whether associations between discrimination and substance use are best explained by symptoms of psychological stress, distress or PTSD. The objectives of the current study were to 1) examine associations between racial discrimination and drug problems among urban-based Aboriginal Canadians, and 2) determine whether these associations were best explained by symptoms of psychological stress, distress or PTSD.
METHODS
We organized and worked collaboratively with an Aboriginal Advisory Committee comprising key stakeholders within the Edmonton Aboriginal community. Together we set study priorities, selected measures and decided how data would be collected. After a pilot study, it was determined that an in-person survey would be administered to a community-based sample of adults who self-identified as Aboriginal in Edmonton. Random sampling was cost-prohibitive given Aboriginal adults make up less than 5% of the population in this city. Instead, participants were recruited using posters placed in public spaces (e.g., stores, malls, coffee shops) and organizations offering social, educational, employment and housing opportunities. Advertisements were also placed in community newspapers and e-newsletters. The range and breadth of advertisement locations were carefully considered, taking into consideration the sociodemographic profile and geographic distribution of Aboriginal peoples in Edmonton. To increase generalizability, snowball sampling was avoided. No advertising took place in drinking establishments or treatment centres. Recruitment adverts asked whether individuals were interested in taking part in an Aboriginal health study and provided contact information to set up a one-on-one appointment with a research assistant.
Data were collected from May to December 2010. Written consent was obtained from all participants. The study protocol was approved by the Human Research Ethics Board at the University of Alberta. Each participant completed a questionnaire package by hand (mean completion time = 70 minutes). Participants were asked whether they would like the questionnaire read to them; all declined. An assistant remained in the room at all times working at another desk to answer questions during survey completion. Each participant was given an honorarium of $25 for his or her time.
Outcome variables
Drug problems were assessed using two applications of the Drug Use Disorders Identification Test (DUDIT), an 11-item psychometrically validated screening tool for drug problems. 16 Scores range from 0 to 44. Validation research suggests that scores 2 standard deviations above the mean may indicate a drug problem, which has translated to ≥6 for men and ≥2 for general populations. The DUDIT has sensitivity and specificity scores of 0.90 and 0.85 respectively when a cut-off of ≥8 is used in a clinical sample. 16, 17 To assess prescription drug problems, the first question was modified from "How often do you use drugs other than alcohol" to "How often do you use prescription pain killers, sedatives, tranquilizers or stimulants?" Remaining items were modified by including "prescription" before "drug" (e.g., how often over the past year have you taken prescription drugs and then neglected to do something you should have done?). To differentiate the second screen for illicit drugs, question 1 was modified to "How often do you use illegal drugs?" Subsequent questions were modified by including "illegal" in front of "drug" for each question. In the current study, the internal consistency of the DUDIT was excellent (α = 0.91 and 0.92 for prescription and illicit drug versions of the measure respectively).
Exposure variable
The Experiences of Discrimination (EOD) Scale is a valid and reliable measure of self-reported racial discrimination that has been used across many ethnic groups. 18 The situation score is derived by counting the number of situations (0 to 9) in which racial discrimination has been experienced. Previous research suggests that Aboriginal Canadians experience high levels of racism; thus the scale was adjusted to measure experiences in the past 12 months to achieve sufficient variability. 19 Each question was worded as follows, with information in brackets reflecting words added and X reflecting the situation tested: (In the past 12 months) have you experienced discrimination, been prevented from doing something, or been hassled or made to feel inferior at X because of your (Aboriginal) race, ethnicity or colour? Internal consistency of the measure in this study was good (α = 0.82). Additional EOD questions examined discrimination experienced in childhood. 18 Mediators PTSD
The PTSD Checklist (PCL)-Civilian Version assessed PTSD symptoms. 20 The measure assesses 17 symptoms occurring in the past month, ranging from 1 (not at all) to 5 (extremely). Items were summed to obtain a total score (range = 17 to 85). A metaanalysis of the PCL concluded that it is a well-validated measure with good temporal stability, internal consistency, test-retest reliability, and convergent validity across ethnically diverse populations. 21 In the current study, internal consistency was excellent (α = 0.95).
Psychological Stress
The 10-item Perceived Stress and Coping Scale is one of the most widely used measures of psychological stress. Items assess the extent to which individuals have experienced symptoms of stress in the past month using a 5-point scale from "never" to "often". 22 Scores range from 0 to 40. In the current study, the internal consistency was good (α = 0.85).
Psychological Distress
The 12-item General Health Questionnaire is a widely used psychological distress screen. Items assess the severity of general psychological distress in the past few weeks using a 4-point scale from "much less than usual" to "more than usual". Scores range from 0 to 36. 23 In the current study, internal consistency was good (α = 0.82).
Covariates
Gender, age, marital status, education, employment and household income were assessed. Consistent with previous studies, a large percentage of Aboriginal adults left income blank (40.4%). 19 As this was anticipated, participants were also asked if they had experienced poverty in their lifetime (never, as a child only, as an adult only, all my life). Few (2%) left this question blank. This variable was used to adjust for poverty across the life course. To control for other forms of trauma shown to influence PTSD and substance abuse, participants were asked whether they had been separated from their parents in childhood (yes or no) and whether they had experienced physical or sexual abuse in childhood (yes or no). 24 Enculturation and acculturation were measured using the Vancouver Index 25 and were controlled for in models given that each has been associated with discrimination and substance use. 19, 26, 27 Analysis strategy
Associations between discrimination and drug problems were examined using bootstrapped linear regression models and 95% confidence intervals (CIs) (k = 5000). 28 All variables were analyzed in continuous form and adjusted for confounders selected a priori using existing literature (age, gender, education, marital status, unemployment status, life course poverty, childhood trauma). Statistical interactions were examined using Loess curves and hierarchical F tests; 29 none were found.
Mediation was examined using a multivariate approach to the cross-products of coefficients method developed by Preacher and Hayes. 28 A total of 5,000 random samples of the original size were taken from the data with replacement, and the indirect effect (a*b) was computed for each sample ( Figure 1 ). The point estimate of the indirect effect was the mean a*b value computed over the samples, with 95% CIs derived from the obtained distribution of a*b scores. 24 If the upper and lower bounds of these bias-corrected CIs did not contain zero, the indirect effect was significant. Only values that reached conventional levels of significance (p ≤ 0.05) were interpreted.
RESULTS
The mean age of participants was 35.2 years (SD = 11.5, range = 18 to 79 years). The sample included approximately 20% more women than men, which is consistent with the gender distribution of Aboriginal adults in Edmonton (Table 1) . 30 Reported household income and educational attainment also matched populationbased estimates. There were more unmarried and unemployed participants than would be expected if random sampling had been used. 30 About a quarter of the sample had never lived in poverty, while 30% had lived in poverty all their lives. On average, participants had lived in Edmonton for 15 years (SD = 12.3, range 0.8 to 60 years).
Racial discrimination
Approximately 8 in 10 participants had experienced discrimination due to Aboriginal race in the past year, most frequently in public spaces, stores and restaurants, and at work. Krieger and colleagues define high and moderate discrimination by situation scores of 3 to 9 and 1 to 2 respectively. 31 Using these criteria, 51.3% of Aboriginal adults experienced high and 29.8% moderate levels of discrimination in the past year (M = 3.3 situations, SD = 2.7, range = 0-9). Levels of discrimination in the past year were positively correlated with levels experienced in childhood (r = 0.49, p < 0.001), highlighting the importance of viewing discrimination as a life course variable. The extent to which participants were engaged in Aboriginal culture was associated with more frequent discrimination in the past year (partial r = 0.15, p = 0.008 adjusting for age, gender, education, unemployment, marital status and poverty).
Discrimination and drug problems
The mean prescription drug problem score the strongest correlates of illicit drug problems in this study. Racial discrimination was significantly and positively associated with prescription drug problems in unadjusted and adjusted models ( Table 2) .
Post-traumatic Stress as a Mediator
Post-traumatic stress scores ranged from 17 to 85 (M = 40.0, SD = 15.9). Mediators of the association between discrimination and illicit drug score were not tested given that the c pathway was not significant. A mediational analysis of the association between discrimination and prescription drug score began with a test of pathway a (Figure 1 ). Using the Preacher and Hayes method, the association between past-year discrimination (exposure) and PTSD symptomology (outcome) was tested in a bootstrapped, fully adjusted model. As shown in Figure 2 , PTSD score increased by 1.22 points for each additional situation in which racism was experienced over the past year. PTSD symptomology was also significantly associated with prescription drug problems (i.e., pathway b). Next, the indirect ab pathway was computed across 5,000 random samples of the original size with replacement. The indirect effect (ab) was automatically computed for each sample. The mean ab value (point estimate) obtained from the bootstrapped distribution of ab scores was 0.18 (bootstrapped standard error [SE] = 0.06, bias corrected 95% CI 0.07-0.31). Given that the upper and lower bounds of the CI did not contain zero, the indirect effect was significant, implying that PTSD symptomology mediated the association between exposure to discrimination and prescription drug problems. Discrimination was no longer significantly associated with prescription drug problems once PTSD score was included in the model (B = 0.33, p = 0.06), suggesting that PTSD symptomology partially accounted for this association.
Testing Alternative Mediators
Psychological stress and distress scores ranged from 2 to 37 (M = 19.0, SD = 5.90) and 0 to 34 (M = 15.6, SD = 6.16) respectively. The analysis described above was rerun to test these variables as mediators. As shown in Table 3 , psychological stress was significantly associated with prescription drug problems (partial r = 0.18, p < 0.05) but not with discrimination (partial r = 0.09, p > 0.05) in an adjusted model. The indirect mean ab value was 0.05 (bootstrapped SE = 0.03, bias corrected 95% CI 0.01-0.13) and thus non-significant, suggesting psychological stress did not mediate the association between experiences of racism and drug problem score. Similarly, psychological distress was associated with prescription drug problems (partial r = 0.24, p < 0.01) but not with discrimination (partial r = 0.01, p > 0.05) in an adjusted model. The indirect mean ab value was 0.007 (bootstrapped SE = 0.05, bias corrected 95% CI 0.09-0.09), suggesting psychological distress did not mediate the association between experiences of racism and drug problem score. In a final step, psychological stress, distress and PTSD scores were examined as mediators in the same model, thus adjusting for the covariance between them. PTSD remained a significant mediator in this model (indirect mean ab value = 0.15, bootstrapped SE = 0.06, bias corrected 95% CI 0.05-0.29). Neither psychological stress nor distress was statistically significant in the omnibus model.
DISCUSSION
High levels of discrimination were reported by Aboriginal adults living in a mid-sized city in western Canada. Discrimination has been associated cross-sectionally with lifetime prescription drug use and prospectively with substance use problems. 7, 32 This study builds on these findings using more proximate measures, documenting a positive association between racial discrimination experienced in the past year and prescription Table 2 .
Bootstrapped point estimates and bias-corrected 95% confidence intervals (CIs) for the direct effects of racial discrimination on prescription drug problem score* Figure 2 . Mediation of association between racial discrimination and prescription drug problems by PTSD symptoms using unstandardized bootstrapped regression coefficients (95% confidence intervals) adjusted for confounders, psychological stress and distress drug problems in the past year. In a fully adjusted model, prescription drug problem score increased by one-half point for each additional situation in which discrimination was experienced in the past year. This increase is substantial given validation studies recommend women with DUDIT scores of 2 and men with DUDIT scores of 6 undergo diagnostic testing for a drug use disorder. 16, 17 This study also documents a positive association between racism experienced in the past year and PTSD symptoms experienced in the past month that could not be explained by other events such as childhood separation from parents, abuse in childhood and exposure to poverty over the life course. In mediation models, PTSD symptoms explained the association between racial discrimination and prescription drug problems among Aboriginal adults; general psychological stress and distress did not. PTSD symptoms also explained this association when the covariance between psychological mediators was controlled, suggesting that symptoms specific to post-traumatic stress (e.g., feeling watchful/on guard, feeling jumpy, feeling one's future may be cut short) explained the association between discrimination and prescription drug problems rather than general symptoms of stress (e.g., feeling stressed/worried, loss of interest in normal activities, difficulty concentrating).
A model that may be derived from these findings posits that racial discrimination results in states of distress and suffering consistent with PTSD symptoms, and that Aboriginal adults who experience high levels of racism may develop prescription drug problems in their efforts to cope with these experiences. It is acknowledged that the current study cannot infer temporal sequence. However, the form of discrimination measured in this study is based on race, a characteristic that does not vary within an individual over time. Thus, it may be argued that race-based discrimination is a fixed marker over the life course, making it, by definition, an antecedent to outcomes such as PTSD and drug problems. 33 The current findings support this assertion, documenting a positive correlation (r = 0.49) between levels of racial discrimination experienced in childhood and levels of discrimination experienced in the past year as an adult.
This study also found that Aboriginal adults living in an urban setting who participated in their cultural traditions experienced a backlash through more frequent experiences of discrimination, replicating previous research in Canada and Australia. 19, 26 Racial identity development, which often includes increased cultural participation, has been recommended as a coping strategy for racism. 34 The current findings combine with others to suggest that this is not enough. Efforts to strengthen Aboriginal identity and cultural continuity in cities must take place alongside efforts to decrease the amount of racial discrimination Aboriginal people experience in the urban environment. These findings also suggest that future research examining the impacts of Aboriginal cultural traditions on health should consider discrimination as a potential confounder of these associations in statistical models. The limitations of this study include the use of a crosssectional design, self-report measures and a volunteer sample of participants. Prospective studies are needed to replicate the associations documented and test the temporal sequence of events implied by these findings. Larger samples are needed to replicate the non-significant association between discrimination and illicit drug problems after adjustment for confounders, as this association has been documented both cross-sectionally and longitudinally among other ethnic groups. 5, 7 The strengths of the study include guidance by an Aboriginal Advisory Committee, past-year assessments of exposures and outcomes, the use of validated measures, adjustment for confounders, and the testing of alternative mediators.
CONCLUSIONS
Most efforts to address Aboriginal health inequities in Canada have focused on the role Aboriginal people play in these disparities and the changes these populations need to make to resolve them. The current findings combine with others to call for an expanded focus. Non-Indigenous Canadians may also play a role in the health inequities observed. Discrimination arises from social arrangements that are potentially remedial. 10 The findings of this study suggest efforts to reduce the amount of racial discrimination experienced by Aboriginal adults in cities may reduce PTSD symptomology and prescription drug problems in these populations. RÉSULTATS : Plus de 80 % des adultes autochtones avaient subi de la discrimination raciale au cours de l'année antérieure, la majorité indiquant des niveaux élevés de discrimination durant cette période. La discrimination au cours de l'année antérieure était un facteur de risque pour les symptômes d'ESPT et les abus de médicaments sur ordonnance dans les modèles ajustés en fonction des facteurs confusionnels et d'autres formes de traumatisme psychologique. Dans les modèles de médiation, les symptômes d'ESPT expliquaient l'association entre la discrimination et l'abus de médicaments sur ordonnance; le stress psychologique et la détresse ne l'expliquaient pas. Les symptômes d'ESPT expliquaient aussi cette association après ajustement pour tenir compte de la covariance entre les médiateurs. Les résultats montrent également que la participation aux traditions culturelles autochtones était associée à une discrimination accrue.
CONCLUSION : La plupart des efforts pour aborder les iniquités en santé chez les Autochtones du Canada portent sur le rôle joué par les Autochtones dans ces disparités. Nos constatations, combinées à celles d'autres chercheurs, justifient un élargissement de cette perspective. Les Canadiens non autochtones pourraient aussi jouer un rôle dans les iniquités en santé observées. Les constatations de notre étude indiquent que des efforts pour réduire la discrimination vécue par les adultes autochtones dans les villes pourraient réduire les symptômes d'ESPT et les abus de médicaments sur ordonnance dans ces populations.
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